Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Environmental Science & Technology, 2024
OMICs Signatures Linking Persistent Organic Pollutants to Cardiovascular Disease in the Swedish Mammography Cohort

Schillemans T., Yan Y., Ribbenstedt A. et al.

Olink Target 96CVDEnvironmental Health & ToxicologyPathophysiologyPatient StratificationPlasma

Circulation Research, 2024
Directional Endothelial Communication by Polarized Extracellular Vesicle Release

Raju S., Botts S., Blaser M. et al.

Olink Target 96CVDPathophysiologyCell Culture Supernatant

Nature Biotechnology, 2024
Discovery of sparse, reliable omic biomarkers with Stabl

Hédou J., Marić I., Bellan G. et al.

Olink Explore 3072/384Wider Bioinformatics StudiesData SciencePlasma

Journal of Crohn's and Colitis, 2023
Baseline Serum and Stool Microbiome Biomarkers Predict Clinical Efficacy and Tissue Molecular Response After Ritlecitinib Induction Therapy in Ulcerative Colitis

Hassan-Zahraee M., Ye Z., Xi L. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPatient StratificationSerumTissue Lysate

International Journal of Obesity, 2023
Sex-specific association of visceral and subcutaneous adipose tissue volumes with systemic inflammation and innate immune cells in people living with obesity

van den Munckhof I., Bahrar H., Schraa K. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

Biomarkers, 2023
Relationships between Charlson comorbidity index associated biomarkers and outcomes among participants in the Malmö diet and cancer study

Wessman T., Ruge T., Carlsson A. et al.

Olink Target 96CVDPatient StratificationSerum

Journal of Clinical Immunology, 2023
Plasma Levels of mir-34a-5p Correlate with Systemic Inflammation and Low Naïve CD4 T Cells in Common Variable Immunodeficiency

Nyström S., Hultberg J., Blixt E. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

British Journal of Cancer, 2023
Associations of diabetes, circulating protein biomarkers, and risk of pancreatic cancer

Pang Y., Lv J., Wu T. et al.

Olink Target 96OncologyPathophysiologyPlasma

Environmental Toxicology and Pharmacology, 2023
Inflammation-related proteins in blood after dermal exposure to some common chemicals depend on the skin barrier gene filaggrin - a human experimental study

Liljedahl E., Gliga A., de Paula H. et al.

Olink Target 96Environmental Health & ToxicologyPathophysiologySerum

Blood Advances, 2023
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204)

Phillips T., Avigdor A., Gurion R. et al.

Olink Target 96OncologyPathophysiologySerum

Cancer Research Communications, 2023
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study

Munster P., Iannotti N., Cho D. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

eBioMedicine, 2023
Circulating biomarkers in familial cerebral cavernous malformation

Lazzaroni F., Meessen J., Sun Y. et al.

Olink Target 96Neurovascular DiseasesPatient StratificationPlasma

Cancers, 2023
Interleukin-6 Induces Stem Cell Propagation through Liaison with the Sortilin–Progranulin Axis in Breast Cancer

Berger K., Persson E., Gregersson P. et al.

Olink Target 96OncologyPathophysiologyCell Culture Supernatant

Nature, 2023
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis

LaMarche N., Hegde S., Park M. et al.

Olink Target 96OncologyPathophysiologySerum

Cardiology and Therapy, 2023
Dual-Pathway Inhibition with Rivaroxaban and Low-Dose Aspirin Does Not Alter Immune Cell Responsiveness and Distribution in Patients with Coronary Artery Disease

Groh L., Willems L., Fintelman P. et al.

Olink Target 96CVDPathophysiologyPlasma

Blood Advances, 2023
Clinical and immunological features in ACKR1/DARC-associated neutropenia

Palmblad J., Sohlberg E., Nilsson C. et al.

Olink Target 96HematologyPatient StratificationPlasma

eBioMedicine, 2023
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial

Zhang X., Irajizad E., Hoffman K. et al.

Olink Target 96OncologyNutritional SciencePathophysiologyPlasma

Cancers, 2023
Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor

Stensgaard S., Thomsen A., Helstrup S. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Scientific Reports, 2023
Changes in natural killer and T lymphocyte phenotypes in response to cardiovascular risk management

Good E., Åkerman L., Nyström S. et al.

Olink Target 96CVDPathophysiologyPlasma

Pediatric Research, 2023
Antisecretory factor in breastmilk is associated with reduced incidence of sepsis in preterm infants

Gustafsson A., Johansson E., Henckel E. et al.

Olink Target 96Infectious DiseasesObstetricsPathophysiologyPlasma

3478 publications